BTIG Downgrades Poseida Therapeutics, Inc (PSTX) to Neutral

November 26, 2024 6:47 AM EST Send to a Friend
BTIG analyst Justin Zelin downgraded Poseida Therapeutics, Inc (NASDAQ: PSTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login